Scientific Advisory Board
Integrated Drug Discovery
Disease Based Models
World Pharma News
Viriom, Inc. announced the initiation of a Phase 2 clinical study to evaluate the efficacy of elsulfavirine in adults with moderate manifestations of COVID-19 (novel coronavirus).
San Diego, CA --(PR NEWS WIRE) --April 8, 2020 -- Viriom, Inc. today announced the initiation of a Phase 2 clinical ...
Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Viriom Inc (Viriom) announces launching Segment I and Segment II reproductive toxicity studies ...
New article “A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling”
Congratulations to Nikolay Savchuk and Matthew Parker, with the release of the article “A Selective Ligand ...
ChemRar Announced Successful Completion of Phase II Clinical Trials of AB5080
ChemRar, a Russian pharmaceutical research company, has announced the successful completion of the second phase of clinical trials ...